Ebrahim S. Public health implications of ageing. J Royal Coll Phys 1995; 29: 207–215.
Manton KG, Stallard E, Liu K. Forecast of active life expectancy: Policy and fiscal implications. J Gerontol 1993; 48: 11–26.
World health statistics annual — 1993. Geneva: Word Health Organisation, 1994.
Kohn RR. Cause of death in very old people. JAMA 1982; 247: 2793–2797.
Lee DJ, Mrakides KS. Activity and mortality among aged persons over an eight-year period. J Gerontol 1990; 45: 39–42.
Levi F, La Vecchia C, Lucchini F, et al. Worldwide trends in cancer mortality in the elderly, 1955–1992. Eur J Cancer 1996; 32: 652–672.
Miller RA. Gerontology as oncology. Research of ageing as the key to the understanding of cancer. Cancer 1991; 68: 2496–2501.
Smith DWE. Cancer mortality at very old ages. Cancer 1996; 77: 1367–1372.
Ruigómez A, Alonso J, Antó MJ. Relationship of health behaviours to five-years mortality in an elderly cohort. Age and Ageing 1995; 24: 113–119.
Kaesberg PR, Ershler WB. The importance of immunesenescence in the incidence and malignant properties of cancer in hosts of advances age. J Gerontol 1989; 44: 63–66.
Kaesberg PR, Ershler WB. The change in tumour aggressiveness with age: Lessons from experimental animals. Semin. Oncol 1989; 16: 28–33.
Casiglia E, Spolaore P, Mormino P, et al. The CASTEL project (CArdiovascular STudy in the ELderly): Protocol, study design, and preliminary results of the initial survey. Cardiologia 1991; 36: 569–576.
Casiglia E, Spolaore P, Ginocchio G, Colangeli G, Di Menza G, Marchioro M, Mazza A, Ambrosio GB. Predictors mortality in very old subjects aged 80 years or over. The CASTEL (CArdiovascular STudy in the ELderly). Eur J Epidemiol 1993; 9: 577–586.
Casiglia E, Spolaore P, Ginocchio G, Colangeli G, Maschio O, Marchioro M, Lanzieri M, Ambrosio GB. Proteinuria predicts mortality among elderly but not among ‘very older’ subjects. J Nephrol 1992; 5: 89–93.
Descovich GC, Dalmonte G, Dormi A, Braiato A, Mannino G, Benassi MS, Gaddi A, Sangiorgi Z, Trivelli N, Lenzi S. The Brisigella Study: A comunity survey. In: Lenzi S, Descovich GC (eds), Atherosclerosis and cardiovascular disease. Norwell MA, USA: MPT Press, 1987: 215–222.
Zanetti G, Colussi P, Pagnan A, Dal Palù C. Comportamento della colesterolemia totale nei pazienti affetti da neoplasie maligne: studio epidemiologico trasversale. Gior Arterioscl 1990; 15: 85–90.
Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular survey methods. Geneva: World Health Organisation, 1982.
Block WD, Jarnet MJ Jr., Levine JR. Improved automated determination of serum total cholesterol with a single reagent. In: Skeggs LT Jr. (ed), Automation in analytical chemistry. New York: Mediad, 1965.
Cox DR. Regression models and life tables. J Roy Statist Soc, Series B 1972; 34: 187–220.
Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
Yancik R, Ries LA. Cancer in older persons. Magnitude of the problem — how do we apply what we know? Cancer 1994; 74: 1995–2003.
Yancik R, Ries GL. Cancer in the aged. An epidemiologic perspective on treatment issues. Cancer 1991; 68: 2502–2510.
La Vecchia C, Negri E, Decarli A, et al. Cancer mortality in Italy: An overview of age-specific and age-standardised trends from 1955 to 1984. Tumori 1990; 76: 87–166.
Decarli A, La Vecchia C. Cancer mortality in Italy, 1988. Tumori 1992; 78: 69–74.
La Vecchia C, Negri E, Decarli A, et al. Cancer mortality in Italy, 1989, and an overview of trends from 1955 to 1989. Tumori 1993; 79: 151–165.
Decarli A, La Vecchia C. Cancer mortality in Italy, 1990. Tumori 1994; 80: 12–18.
Decarli A, La Vecchia C. Cancer mortality in Italy, 1991. Tumori 1994; 80: 405–415.
McLaughlin JK, Hrubec Z, Blot WJ, et al. Smoking and cancer mortality among U.S. veterans: A 26–year follow-up. Int J Cancer 1995; 60: 190–193.
Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates Parkin for 1985. Int J Cancer 1994; 59: 494–504.
Sterling TD, Rosenbaum WL, Weinkam JJ. Analysis of the relationship between smokeless tobacco and cancer based on data from the national mortality followback survey. J Clin Epidemiol 1992; 45: 223–231.
Maier H, Dietz A, Gewelke U, et al. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 1992; 70: 320–327.
Kabat GC, Chang CJ, Wynder EL. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 1994; 23: 1137–1144.
Cambien F, Ducimetiere P, Richard JL. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol 1980; 112: 388–394.
Zureik M, Courbon D, Ducimetiere P. Decline in serum total cholesterol and risk of death from cancer. Epidemiology 1997; 8: 137–143.
Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Research 1988; 48: 2916–2918.
Levine W, Dyer AR, Shekelle RB, et al. Serum uric acid and 11.5 years mortality of middle-aged women: Findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989; 42: 257–267.
Kolonel LN, Yoshizawa C, Nomura AM, et al. Relationship of serum uric acid to cancer occurence in a prospective male cohort. Cancer Epidemiol, Biomarkers & Prev 1994; 3: 225–228.
Rustin GJ. Circulating tumour markers in the management of human cancer. In: Daar AS (ed), Tumour markers in clinical practice: Concepts and applications. Oxford, UK: Blackwell, 1987: 204–227.
Fishman WH. The 1993 ISOBM Abbott Award Lecture. Isoenzymes, tumour markers and oncodevelopmental biology. Tumour Biol 1995; 16: 394–402.
Millan JL, Fishman WH. Biology of human alkaline phosphatases with special reference to cancer. Crit Rev Clin Lab Sci 1995; 32: 1–39.
Bacci P, Picci P, Ferrari S. Prognostic significance of serum AP in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy. Cancer 1993; 11: 1224–1230.
Chen JM, Zhang YP, Wang C, et al. O6–Methylguanine-DNA methyltransferase activity in human tumours. Carcinogenesis 1992; 13: 1503–1507.
Reuben DB, Mor V. Dyspnea in terminally cancer patients. Chest 1986; 89: 234–236.
Escalante CP, Martin CG, Elting LS, et al. Dyspnea in cancer patients. Etiology, resource utilisation, and survival-implications in a managed care world. Cancer 1996; 78: 1314–1319.
Brown BW, Brauner C, Minotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 1993; 85: 979–987.
Kabat GC, Winder EL. Body mass index and lung cancer risk. Am J Epidemiol 1992; 135: 769–774.
Chyou PH, Nomura AMY, Stemmermann GN. A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancer. Int J Cancer 1994; 57: 313–317.
Vandenbroucke JP, Mauritz BJ, De Bruin A, et al. Wight, smoking and mortality. J Am Diet Assoc 1984; 252: 2859–2860.
Mastrangelo G, Malusa E, Veronese C, et al. Mortality from lung cancer and other diseases related to smoking among fishermen in northeast Italy. Occup Environ Med 1995; 52: 150–153.
Francescon A, Gessoni G, Manoni F, et al. Infezione da virus C nell'anziano: Studio sierologico e valutazione dei fattori di rischio. Gior Geront 1995; 43: 145–151.
Gessoni G, Manoni F, Prosperi A, et al. L'infezione da HCV, importanza come fattore di rischio nel carcinoma epatocellulare. Gior Ven Sc Med 1993; 45: 71–76.
Gessoni G, Manoni F. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: A sieroepidemiological study. Eur J Med 1993; 2: 79–82.